CHEPLAPHARM Arzneimittel GmbH
support_agent

Your contact persons

Archive

01/15/2018

CHEPLAPHARM engaged DKSH to market its regional business in several Asian countries

Zurich (CH) / Greifswald (DE), December 15, 2017 – In a formal ceremony at the DKSH headquarters in Zurich, DKSH and CHEPLAPHARM Arzneimittel GmbH have signed a strategic partnership for a regional…


more chevron_right
Archive

12/13/2017

CHEPLAPHARM reached the final phase of the Axia Awards

According to the motto “We are creating a future with perspectives”, mid-sized companies were honored for their sustainable and successful management by Deloitte and WirtschaftsWoche, together with…


more chevron_right
Archive

09/19/2017

CHEPLAPHARM plans further investments

On the occasion of the visit of the German Chancellor Angela Merkel and the Minister of Economics Harry Glawe at CHEPLAPHARM in Greifswald, CEO Sebastian F. Braun announces further investments of 210…


more chevron_right
Archive

08/09/2017

Mysimba®: Commercialization and distributorship arrangement with Orexigen Therapeutics Ireland, Ltd.

The wholly owned subsidiary of Orexigen Therapeutics, Inc. (OREX), and CHEPLAPHARM Arzneimittel GmbH have executed a distributorship agreement covering Germany, France and Austria for Mysimba®…


more chevron_right
Archive

02/24/2017

50 new employees: CHEPLAPHARM’s successful story continues

The successful company from Greifswald, CHEPLAPHARM Arzneimittel GmbH, continues to grow: 50 new employees have been recruited in the past eight months.


more chevron_right
Archive

10/27/2016

Largest private sector investment in Mecklenburg-Western Pomerania: CHEPLAPHARM makes the megadeal

With an investment of approximately 340 million euros, CHEPLAPHARM Arzneimittel GmbH breaks all private sector records in Mecklenburg-Western Pomerania and moves into the big league for medium-sized…


more chevron_right
Archive

01/20/2016

CHEPLAPHARM acquires product rights for ANEXATE® from F. Hofmann-La Roche

Amount of investment in the mid, double-digit million euro range. CHEPLAPHARM creates eight new jobs with this acquisition.


more chevron_right
Archive

12/02/2015

CHEPLAPHARM assumes Italian rights for ALDACTONE®

CHEPLAPHARM acquired the product rights for the prescription medication ALDACTONE® in Italy on 09.11.2015, thus boosting its presence within this market that is very important to CHEPLAPHARM.


more chevron_right
Archive

12/01/2015

CHEPLAPHARM moves into new 2500 square meter office building at Greifswald’s Business Park Ziegelhof

more chevron_right
Archive

03/05/2015

CHEPLAPHARM Arzneimittel GmbH launches 100 million EURO investment program

more chevron_right
Back to top expand_less